Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04692818 · ClinicalTrials.gov registry record · NA
3D Ultrasound Breast Imaging
A NA study of Breast Tumor, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 1
- Study location
NCT04692818 is a NA study of Breast Tumor that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 125 participants, below the 1,406-participant average among 6 other Breast Tumor trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04692818, a NA study of Breast Tumor, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to study the efficacy of a new ultrasound imaging method for diagnosis of breast mass.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST GE Logiq E10 clinical ultrasound scanner
- DIAGNOSTIC_TEST Verasonics research scanner
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2021-11-10 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04692818
The ClinicalTrials.gov registry entry for NCT04692818 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,406-participant average among 6 other Breast Tumor trials with a reported enrollment target (91% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Tumor appearing as the primary indexed condition, and to 2 interventions - of which GE Logiq E10 clinical ultrasound scanner is the first listed.
NCT04692818 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT04692818 about?
NCT04692818 is a clinical study titled "3D Ultrasound Breast Imaging". The purpose of this research is to study the efficacy of a new ultrasound imaging method for diagnosis of breast mass.
What is the current status of trial NCT04692818?
This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2021-11-10. Estimated completion is 2026-12-31.
What conditions does trial NCT04692818 study?
This clinical trial studies the following conditions: Breast Tumor.
What interventions are being tested in trial NCT04692818?
The interventions under investigation include: GE Logiq E10 clinical ultrasound scanner (DIAGNOSTIC_TEST), Verasonics research scanner (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04692818?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04692818 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Radiofrequency Chip for Localization of Non-Palpable Breast Lesions
COMPLETED · NA
-
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
RECRUITING
-
A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer
RECRUITING · Phase 1
-
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
RECRUITING · Phase 2
-
Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients
ACTIVE NOT RECRUITING · Phase 2
-
Proton Radiation for Stage II/III Breast Cancer
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.